Quick Answer
CHEMED CORP reported Total Revenue of $2.53 billion for fiscal year 2025.
CHEMED CORP — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $2.53B +4.1% |
$2.43B +7.4% |
$2.26B +6.1% |
$2.13B -0.2% |
$2.14B +2.9% |
$2.08B +7.3% |
| Net Income | $265.24M -12.2% |
$302.00M +10.8% |
$272.51M +9.2% |
$249.62M -7.0% |
$268.55M -15.9% |
$319.47M +45.3% |
| Diluted EPS | $18.34 -7.8% |
$19.89 +10.9% |
$17.93 +8.5% |
$16.53 -1.9% |
$16.85 -13.5% |
$19.48 +46.4% |
| Total Assets | $1.54B -7.8% |
$1.67B +0.0% |
$1.67B +15.7% |
$1.44B +7.4% |
$1.34B -6.4% |
$1.43B +13.1% |
| Cash and Equivalents | $74.52M -58.2% |
$178.35M -32.4% |
$263.96M +256.1% |
$74.13M +125.3% |
$32.90M -79.8% |
$162.68M +2541.7% |
| Long-Term Debt | — | — | — | $92.50M -50.0% |
$185.00M | — |
| Stockholders Equity | $979.40M -12.5% |
$1.12B +1.0% |
$1.11B +38.7% |
$798.72M +28.1% |
$623.27M -30.8% |
$901.20M +24.0% |
| Operating Income | $338.25M -7.7% |
$366.49M +7.6% |
$340.57M -0.9% |
$343.50M +0.1% |
$343.04M -12.0% |
$389.68M +51.4% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $624.90M | +3.1% | +1.0% |
| Net Income | September 30, 2025 | $64.24M | -15.2% | +22.4% |
| Diluted EPS | September 30, 2025 | $4.46 | -10.8% | +24.9% |
| Total Assets | September 30, 2025 | $1.62B | -8.2% | -5.5% |
| Cash and Equivalents | September 30, 2025 | $129.75M | -45.6% | -48.1% |
| Long-Term Debt | March 31, 2023 | $16.25M | -86.5% | -82.4% |
| Stockholders Equity | September 30, 2025 | $1.08B | -12.9% | -10.2% |
| Operating Income | September 30, 2025 | $74.75M | -18.9% | +9.8% |
- CHEMED CORP reported Total Revenue of $2.53 billion for fiscal year 2025.
- CHEMED CORP showed an increase of +4.1% in Total Revenue compared to the prior fiscal year.
- CHEMED CORP reported Net Income of $265.24 million for fiscal year 2025.
- CHEMED CORP showed a decrease of -12.2% in Net Income compared to the prior fiscal year.
- CHEMED CORP reported Diluted EPS of $18.34 per share for fiscal year 2025.
- CHEMED CORP showed a decrease of -7.8% in Diluted EPS compared to the prior fiscal year.
- CHEMED CORP reported Total Assets of $1.54 billion for fiscal year 2025.
- CHEMED CORP showed a decrease of -7.8% in Total Assets compared to the prior fiscal year.
- CHEMED CORP reported Cash and Equivalents of $74.52 million for fiscal year 2025.
- CHEMED CORP showed a decrease of -58.2% in Cash and Equivalents compared to the prior fiscal year.
- CHEMED CORP reported Long-Term Debt of $92.50 million for fiscal year 2022.
- CHEMED CORP showed a decrease of -50.0% in Long-Term Debt compared to the prior fiscal year.
- CHEMED CORP reported Stockholders Equity of $979.40 million for fiscal year 2025.
- CHEMED CORP showed a decrease of -12.5% in Stockholders Equity compared to the prior fiscal year.
- CHEMED CORP reported Operating Income of $338.25 million for fiscal year 2025.
- CHEMED CORP showed a decrease of -7.7% in Operating Income compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: